Sponsored
David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Lightship
Advertisement
Articles by Lightship
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: | Updated:
Sponsored
Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research organization (CRO) partners to support clinical trials that are patient-first and accessible.
Advertisement
Latest Updated Articles
Lightship’s Approach to Accessible, Representative, and Impactful Clinical TrialsPublished: February 13th 2025 | Updated: March 4th 2025
Accelerate Inclusive Enrollment and Delivery with LightshipPublished: February 19th 2025 | Updated: February 26th 2025
- Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: February 13th 2025 | Updated: March 4th 2025
- Accelerate Inclusive Enrollment and Delivery with Lightship
Published: February 19th 2025 | Updated: February 26th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review
2
FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine
3
ACT Brief: FDA Transparency Roadmap, Radiopharmaceutical Trial Operations, and AI-Powered Enrollment Prediction
4
Using AI to Design Better Trials Before the First Patient Enrolls: Q&A with Claire Riches, Citeline
5